| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |